These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 9348175)

  • 1. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells.
    Horváth JE; Zarándi M; Groot K; Schally AV
    Endocrinology; 1995 Sep; 136(9):3849-55. PubMed ID: 7649091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
    Szalontay L; Benveniste RJ; Schally AV; Vidaurre I; Nadji M; Zarandi M; Block NL; Kovacs M
    Neuroendocrinology; 2012; 96(1):81-8. PubMed ID: 22377963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone.
    Zarandi M; Horvath JE; Halmos G; Pinski J; Nagy A; Groot K; Rekasi Z; Schally AV
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12298-302. PubMed ID: 7991622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
    Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G
    J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone.
    Pinski J; Schally AV; Groot K; Halmos G; Szepeshazi K; Zarandi M; Armatis P
    J Natl Cancer Inst; 1995 Dec; 87(23):1787-94. PubMed ID: 7473836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels.
    Yamashita S; Melmed S
    Endocrinology; 1986 Jan; 118(1):176-82. PubMed ID: 3079701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
    Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.
    Szepeshazi K; Schally AV; Groot K; Armatis P; Halmos G; Herbert F; Szende B; Varga JL; Zarandi M
    Br J Cancer; 2000 May; 82(10):1724-31. PubMed ID: 10817510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
    Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
    Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and antineoplastic actions of growth hormone-releasing hormone antagonists.
    Kovács M; Schally AV; Varga JL; Zarándi M
    Curr Med Chem; 2008; 15(4):314-21. PubMed ID: 18288987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
    Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
    Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of GHRH aggravated acetaminophen-induced acute mice liver injury through GH/IGF-I axis.
    Wang T; Hai J; Chen X; Peng H; Zhang H; Li L; Zhang Q
    Endocr J; 2012; 59(7):579-87. PubMed ID: 22572547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.
    Jungwirth A; Schally AV; Pinski J; Groot K; Armatis P; Halmos G
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5810-3. PubMed ID: 9159156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.
    Szepeshazi K; Schally AV; Groot K; Armatis P; Hebert F; Halmos G
    Eur J Cancer; 2000 Jan; 36(1):128-36. PubMed ID: 10741306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor.
    Kovacs M; Schally AV; Lee EJ; Busto R; Armatis P; Groot K; Varga JL
    J Endocrinol; 2002 Nov; 175(2):425-34. PubMed ID: 12429040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.